Food and Drug Administration
Transmissible Spongiform Encephalopathy Advisory Committee
February 20, 2003
Briefing Information
Issue Summary for Topic #1, "Consideration of Labeling Claims
for Transmissible Spongiform Encephalopathy (TSE) Agent Clearance in Plasma
Derivaties" (HTM) (PDF)
(Word)
Bibliography (HTM) (PDF)
(Word)